bluebird bio, Inc. financial data

Location
Somerville, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 14 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 56% % -60%
Quick Ratio 19% % 72%
Debt-to-equity -4285% % -1908%
Return On Equity 1895% %
Return On Assets -45% % 4.8%
Operating Margin -208% % 71%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,790,070 shares
Common Stock, Shares, Outstanding 9,790,000 shares -95%
Entity Public Float $189,220,530 USD -45%
Common Stock, Value, Issued $1,924,000 USD 0.58%
Weighted Average Number of Shares Outstanding, Basic 9,751,000 shares 0.96%
Weighted Average Number of Shares Outstanding, Diluted 9,751,000 shares 0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $103,946,000 USD 128%
Revenue from Contract with Customer, Excluding Assessed Tax $103,946,000 USD 129%
Cost of Revenue $75,753,000 USD 41%
Research and Development Expense $86,901,000 USD -43%
Costs and Expenses $244,569,000 USD -25%
Operating Income (Loss) $216,376,000 USD 35%
Income Tax Expense (Benefit) $170,000 USD
Net Income (Loss) Attributable to Parent $199,980,000 USD 33%
Earnings Per Share, Basic -21 USD/shares 55%
Earnings Per Share, Diluted -21 USD/shares 55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $78,744,000 USD -63%
Inventory, Net $83,283,000 USD 175%
Assets, Current $174,524,000 USD -36%
Property, Plant and Equipment, Net $60,405,000 USD -33%
Operating Lease, Right-of-Use Asset $27,073,000 USD -86%
Intangible Assets, Net (Excluding Goodwill) $9,315,000 USD -9.1%
Goodwill $5,646,000 USD 0%
Other Assets, Noncurrent $18,994,000 USD -67%
Assets $295,957,000 USD -53%
Accounts Payable, Current $42,624,000 USD 120%
Employee-related Liabilities, Current $15,904,000 USD 46%
Liabilities, Current $315,078,000 USD 7.3%
Operating Lease, Liability, Noncurrent $23,571,000 USD -87%
Other Liabilities, Noncurrent $92,000 USD 0%
Liabilities $353,823,000 USD -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,879,000 USD 11%
Retained Earnings (Accumulated Deficit) $4,530,112,000 USD -4.6%
Stockholders' Equity Attributable to Parent $57,866,000 USD -144%
Liabilities and Equity $295,957,000 USD -53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $43,442,000 USD 42%
Net Cash Provided by (Used in) Financing Activities $26,709,000 USD -59%
Net Cash Provided by (Used in) Investing Activities $3,102,000 USD
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 9,790,000 shares -95%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,631,000 USD -28%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $92,312,000 USD -65%
Deferred Tax Assets, Valuation Allowance $1,240,372,000 USD 4%
Deferred Tax Assets, Gross $1,300,877,000 USD 2.9%
Operating Lease, Liability $28,538,000 USD -86%
Payments to Acquire Property, Plant, and Equipment $859,000 USD -52%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $199,751,000 USD 33%
Lessee, Operating Lease, Liability, to be Paid $35,210,000 USD -86%
Operating Lease, Liability, Current $4,967,000 USD -80%
Lessee, Operating Lease, Liability, to be Paid, Year Two $5,187,000 USD -85%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,053,000 USD -86%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,672,000 USD -87%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,324,000 USD -86%
Deferred Tax Assets, Operating Loss Carryforwards $781,085,000 USD 7.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $24,538,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,821,000 USD -90%
Operating Lease, Payments $4,432,000 USD 56%
Additional Paid in Capital $4,472,201,000 USD 0.24%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $11,635,000 USD -35%
Interest Expense $16,939,000 USD 14%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%